REG - Alpha Growth PLC - Change of Adviser

Alpha GrowthAnnouncement

27/10/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221027:nRSa2224Ea&default-theme=true

RNS Number : 2224E  Alpha Growth PLC  27 October 2022

27 October 2022

Alpha Growth plc

("Alpha" or the "Company")

Appointment of Broker

Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services
specialist in the growing longevity asset class, is pleased to announce the
appointment of Allenby Capital Limited ("Allenby Capital") as the Company's
sole Broker with effect from today.

Allenby Capital currently advises or is broker to over 70 corporate clients
listed on AIM, the Standard List or AQUIS markets. Allenby Capital will
provide Alpha Growth access to a broad spectrum of investors including
institutional investors, family offices, private client brokers and high net
worth individuals.

Gobind Sahney, Chairman, stated - "I am exceptionally pleased to announce the
appointment of Allenby Capital as the Company's broker, I have been impressed
by Allenby's approach to date and the speed at which they have understood the
business, and look forward to working with them to introduce Alpha to a new
cohort of retail and institutional investors."

For more information, please visit www.algwplc.com or contact the following:

 Alpha Growth Plc                                   +44 (0) 20 3959 8600
 Gobind Sahney, Executive Chairman                  info@algwplc.com (mailto:info@algwplc.com)
 Allenby Capital Limited                            +44 (0) 20 3328 5656
 Amrit Nahal (Sales and Corporate Broking)
 Nick Athanas / Piers Shimwell (Corporate Finance)
 UK Investor Relations - Mark Treharne              ir@algwplc.com (mailto:ir@algwplc.com)

 

About Alpha Growth plc

Specialist in Longevity Assets

Alpha Growth plc is a financial advisory business providing specialist
consultancy, advisory, and supplementary services to institutional and
qualified investors globally in the multi-billion dollar market of life
insurance linked longevity assets. Building on its well-established network,
the Alpha Growth Group has a unique position in the longevity asset services
and investment business, as a listed entity with global reach. The Group's
strategy is to expand its advisory and business services via acquisitions and
joint ventures in the UK and the US to attain commercial scale and provide
holistic solutions to alternative institutional investors who are in need of
specialised skills and unique access to deploy their financial resource in
longevity assets.

Longevity Assets and Non-correlation

As a longevity asset, it is non-correlated to the real estate, equity capital
and commodity markets.  Its value is a function of time because as time
passes the value gets closer to the face value of the policy. Hence creating a
steady increase in the net asset value of the investment. This makes it highly
attractive to investors wishing to counteract volatility within an investment
portfolio and add yield.

Note: The Company only advises on and manages Longevity Assets that originate
in the USA where the structured and life settlement market is highly
regulated.

Important Notice

The content of this announcement has not been approved by an authorised person
within the meaning of the Financial Services and Markets Act 2000 (FSMA). This
announcement has been issued by and is the sole responsibility of the Company.
The information in this announcement is subject to change.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPFEEFEMEESELS